World's Best Scientists 2026 revealed!
Stefan K. Bohlander

Stefan K. Bohlander

Award Badge
Biology and Biochemistry
New Zealand
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
20350
World Ranking
4798
National Ranking
10

Stefan K. Bohlander publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Stefan K. Bohlander sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 336 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Stefan K. Bohlander D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan K. Bohlander sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in New Zealand Leader Award
  • 2025 - Research.com Biology and Biochemistry in New Zealand Leader Award

Overview

Stefan K. Bohlander is affiliated with the University of Auckland in New Zealand. Their research contributions are primarily situated within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on hematology and molecular biology subfields.

The scientist's work spans several key subfields including:

  • Hematology
  • Molecular Biology
  • Immunology
  • Genetics
  • Cell Biology

Research topics covered by Stefan K. Bohlander include:

  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Cancer Genomics and Diagnostics
  • Interferon and immune responses

Their scientific output is frequently published in several established venues, notably:

  • Blood
  • Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • European Journal of Human Genetics

Recent papers authored or co-authored by Stefan K. Bohlander include:

  • Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia, 2020, Leukemia
  • Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy, 2020, Journal of Clinical Oncology
  • The clinical mutatome of core binding factor leukemia, 2020, Leukemia
  • Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia, 2020, Leukemia
  • Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance, 2020, Blood

Frequent collaborators include:

  • Purvi M. Kakadia
  • Julie A.I. Thoms
  • John E. Pimanda
  • Golam Sarower Bhuyan
  • Christopher J. Jolly

Best Publications

  • Stem cell gene expression programs influence clinical outcome in human leukemia

    Kolja Eppert;Katsuto Takenaka;Eric R Lechman;Levi Waldron

  • Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

    T R Golub;G F Barker;S K Bohlander;S W Hiebert

  • MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

    Shuangli Mi;Jun Lu;Jun Lu;Miao Sun;Zejuan Li

  • Distinct microRNA expression profiles in acute myeloid leukemia with common translocations

    Zejuan Li;Jun Lu;Jun Lu;Miao Sun;Shuangli Mi

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

    Klaus H. Metzeler;Klaus H. Metzeler;Tobias Herold;Tobias Herold;Maja Rothenberg-Thurley;Susanne Amler

  • An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.

    Klaus H. Metzeler;Manuela Hummel;Clara D. Bloomfield;Karsten Spiekermann

  • Clathrin Assembly Lymphoid Myeloid Leukemia (CALM) Protein: Localization in Endocytic-coated Pits, Interactions with Clathrin, and the Impact of Overexpression on Clathrin-mediated Traffic

    Francesc Tebar;Stefan K. Bohlander;Alexander Sorkin

  • Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.

    T. R. Golub;A. Goga;G. F. Barker;D. E. H. Afar

  • Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

    Annika Dufour;Friederike Schneider;Klaus H. Metzeler;Eva Hoster

  • The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family

    M H Dreyling;J A Martinez-Climent;M Zheng;J Mao

  • Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia

    John A. Pulikkan;Viola Dengler;Philomina S. Peramangalam;Abdul A. Peer Zada

  • Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.

    Jennifer A. Pietenpol;Stefan K. Bohlander;Yuko Sato;Nickolas Papadopoulos

  • The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

    Christina Schessl;Vijay P.S. Rawat;Monica Cusan;Aniruddha Deshpande

  • A Mutation in the 5′-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus

    Oliver Semler;Lutz Garbes;Katharina Keupp;Daniel Swan

  • A method for the rapid sequence-independent amplification of microdissected chromosomal material.

    Stefan K. Bohlander;Rafael Espinosa;Michelle M. Le Beau;Janet D. Rowley

  • Whole exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations

    Martin Neumann;Sandra Heesch;Cornelia Schlee;Stefan Schwartz

  • ETV6: a versatile player in leukemogenesis.

    Stefan K. Bohlander

  • Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations

    Hanna S. Radomska;Daniela S. Bassères;Rui Zheng;Pu Zhang

  • Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study

    Zejuan Li;Tobias Herold;Chunjiang He;Peter J.M. Valk

Frequent Co-Authors

Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Helmut Blum
Helmut Blum Ludwig-Maximilians-Universität München
Guoliang Xu
Guoliang Xu Fudan University
Scott A. Armstrong
Scott A. Armstrong Harvard University
Janet D. Rowley
Janet D. Rowley University of Chicago
Todd R. Golub
Todd R. Golub Harvard University
Achim Heinecke
Achim Heinecke University of Münster
Jianjun Chen
Jianjun Chen University of Cincinnati
Olufunmilayo I. Olopade
Olufunmilayo I. Olopade University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Stefan K. Bohlander

Trending Scientists

Recently Published Articles